Is there a role for urokinase-type plasminogen activator inhibitors as maintenance therapy in patients with ovarian cancer?
Author:
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference65 articles.
1. Evolving role of uPA/uPAR system in human cancers;Dass;Cancer Treat Rev,2008
2. Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin;Dunbar;Expert Opin Investig Drugs,2000
3. Clinical relevance of the plasminogen activator inhibitor type 1 – a multifaceted proteolytic factor;Harbeck;Onkologie,2001
4. uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies;Duffy;Breast Cancer Res,2014
5. Prognostic significance of UPA and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc;Kuhn;Br J Cancer,1999
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of Rabbit Bone Marrow Mesenchymal Stem Cell Transplantation on Anterior Cruciate Ligament Injury Repair and Related Serum Indicators;Pharmaceutical Chemistry Journal;2024-06
2. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis;2024-05-08
3. uPAR, beyond regulating physiological functions, has orchestrated roles in cancer (Review);International Journal of Oncology;2022-10-18
4. The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine;International Journal of Molecular Sciences;2022-09-01
5. Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinoma;Journal of Biological Chemistry;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3